Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | JB272A | IM / LA |
It was discovered after the fact that this patient had already received a dose if the Arexvy vaccine on 10/05/2023. Patient has not had any adverse reactions and is aware that she received two doses and does not ever need another dose.
None
Hypertension, Glaucoma
Unknown
None